90 related articles for article (PubMed ID: 25948180)
1. [Comparison of the Tumor-forming Rate between the SCID and NOD/SCID Mice used to Set up Acute Myeloid Leukemia Model].
Yang H; Liu JX; Zhou ZP; Liu L; Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):328-34. PubMed ID: 25948180
[TBL] [Abstract][Full Text] [Related]
2. Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice.
Ferretti E; Montagna D; Di Carlo E; Cocco C; Ribatti D; Ognio E; Sorrentino C; Lisini D; Bertaina A; Locatelli F; Pistoia V; Airoldi I
Leukemia; 2012 Feb; 26(2):225-35. PubMed ID: 21844875
[TBL] [Abstract][Full Text] [Related]
3. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
4. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
[TBL] [Abstract][Full Text] [Related]
5. MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+ / CD131- epitope expressed by leukemia stem cells.
Leyton JV; Williams B; Gao C; Keating A; Minden M; Reilly RM
Leuk Res; 2014 Nov; 38(11):1367-73. PubMed ID: 25278187
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
Bergstrom D; Leyton JV; Zereshkian A; Chan C; Cai Z; Reilly RM
Nucl Med Biol; 2016 Oct; 43(10):635-41. PubMed ID: 27497632
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-27 inhibits the growth of pediatric acute myeloid leukemia in NOD/SCID/Il2rg-/- mice.
Zorzoli A; Di Carlo E; Cocco C; Ognio E; Ribatti D; Ferretti E; Dufour C; Locatelli F; Montagna D; Airoldi I
Clin Cancer Res; 2012 Mar; 18(6):1630-40. PubMed ID: 22383738
[TBL] [Abstract][Full Text] [Related]
8. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.
Monaco G; Konopleva M; Munsell M; Leysath C; Wang RY; Jackson CE; Korbling M; Estey E; Belmont J; Andreeff M
Stem Cells; 2004; 22(2):188-201. PubMed ID: 14990858
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of anti-CD47 antibody and Ara-C combination targeting therapy NOD/SCID mouse of myeloid leukemia].
Wang YC; Feng L; Yin CY; Ma LN; Wei YW; Wang CM; Sheng GY
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):577-82. PubMed ID: 23866283
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of Human Acute B-Lymphoblastic Leukemia--NOD/SCID Xenotransplant Mouse Model].
Zhang X; Deng Y; Chen FL; Fang YJ; Zhang W; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):623-6. PubMed ID: 26117005
[TBL] [Abstract][Full Text] [Related]
11. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
12. Angiocidin induces differentiation of acute myeloid leukemia cells.
Tuszynski GP; Rothman VL
Exp Mol Pathol; 2013 Dec; 95(3):249-54. PubMed ID: 24036285
[TBL] [Abstract][Full Text] [Related]
13. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
Baersch G; Möllers T; Hötte A; Dockhorn-Dworniczak B; Rübe C; Ritter J; Jürgens H; Vormoor J
Klin Padiatr; 1997; 209(4):178-85. PubMed ID: 9293448
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice.
Zhong RK; van de Winkel JG; Thepen T; Schultz LD; Ball ED
J Hematother Stem Cell Res; 2001 Feb; 10(1):95-105. PubMed ID: 11276363
[TBL] [Abstract][Full Text] [Related]
15. [Construction and Identification of Acute Myeloid Leukemia NOD/SCID Mouse Model by Tail Vein Injection of THP-1 Cells].
Liao XM; Chen Q; Feng ZX; Yang XM; Zhu CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):424-429. PubMed ID: 32319373
[TBL] [Abstract][Full Text] [Related]
16. [The Establishment and Identification of Acute Myeloid Leukemia NOD-SCID-IL2rg
Zhang WY; Zeng GC; Chen XM; Geng SX; Wang YL; Luo Q; Luo LP; Lai PL; Weng JY; DU X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1429-1435. PubMed ID: 34627421
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of human acute B-lymphoblastic leukemia NOD/SCID/IL2 receptor γ chain(null) neonatal mouse xenotransplant model].
Kong Y; Liu YR; Liu KY; Huang XJ; Ishikawa F; Harada M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):762-8. PubMed ID: 22739198
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of K562/NOD-SCID mouse model with leukemia].
Song YQ; Liu M; Li W; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):16-9. PubMed ID: 17490512
[TBL] [Abstract][Full Text] [Related]
19. Differential survival of AML subpopulations in NOD/SCID mice.
Schubert M; Herbert N; Taubert I; Ran D; Singh R; Eckstein V; Vitacolonna M; Ho AD; Zöller M
Exp Hematol; 2011 Feb; 39(2):250-263.e4. PubMed ID: 21087653
[TBL] [Abstract][Full Text] [Related]
20. [Biodistribution study of 131I-gM-CSF in SCID mice bearing human leukemia].
Xu YZ; Lou SF; Deng YJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):678-81. PubMed ID: 17343200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
